CPWM, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
CPWM, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$1,358,000
+14.0%
31,1810.0%0.10%
+3.2%
Q4 2021$1,191,0000.0%31,1810.0%0.09%
-13.8%
Q3 2021$1,191,000
-4.1%
31,1810.0%0.11%
+17.2%
Q2 2021$1,242,000
+12.0%
31,181
+0.3%
0.09%
-2.1%
Q1 2021$1,109,000
-2.8%
31,078
+0.2%
0.10%
-8.7%
Q4 2020$1,141,000
-2.8%
31,002
-0.6%
0.10%
-15.4%
Q3 2020$1,174,000
-8.6%
31,199
-1.0%
0.12%
-15.8%
Q2 2020$1,285,000
+8.2%
31,502
+0.5%
0.15%
-16.1%
Q1 2020$1,188,000
-18.7%
31,344
+0.8%
0.17%
-2.2%
Q4 2019$1,461,000
+10.1%
31,0950.0%0.18%
+2.3%
Q3 2019$1,327,000
+6.7%
31,0950.0%0.17%0.0%
Q2 2019$1,244,000
-9.2%
31,095
-5.2%
0.17%
-11.7%
Q1 2019$1,370,000
+9.6%
32,794
+0.3%
0.20%
-3.9%
Q4 2018$1,250,000
-8.6%
32,711
-4.0%
0.20%
+5.1%
Q3 2018$1,368,000
-5.6%
34,065
-5.2%
0.20%
-11.4%
Q2 2018$1,449,000
+2.2%
35,951
-1.0%
0.22%
-0.5%
Q1 2018$1,418,000
+353.0%
36,300
+433.9%
0.22%
+93.9%
Q3 2014$313,000
-5.2%
6,799
+10.2%
0.11%
-4.2%
Q2 2014$330,000
+22.2%
6,169
+21.9%
0.12%
+14.4%
Q1 2014$270,000
+18.9%
5,059
+19.0%
0.10%
+18.2%
Q4 2013$227,000
+7.1%
4,2510.0%0.09%
+1.1%
Q3 2013$212,0000.0%4,2510.0%0.09%0.0%
Q2 2013$212,0004,2510.09%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders